Skip to content
Disclosery

Maple-Brown Abbott Ltd: NI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on NI, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 1,872,810 NI shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 1,872,810 shares
    Change vs previous 13F -438,533 shares

    5.12% of the 13F portfolio, value $75,086,977.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 2,311,343 shares
    Change vs previous 13F -756,680 shares

    10.36% of the 13F portfolio, value $84,964,968.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 3,068,023 shares
    Change vs previous 13F -241,200 shares

    10.55% of the 13F portfolio, value $106,306,997.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 3,309,223 shares
    Change vs previous 13F -133,290 shares

    10.05% of the 13F portfolio, value $95,338,715.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 3,442,513 shares
    Change vs previous 13F +656,060 shares

    9.74% of the 13F portfolio, value $95,219,908.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 2,786,453 shares
    Change vs previous 13F +568,980 shares

    7.53% of the 13F portfolio, value $73,980,328.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 2,217,473 shares
    Change vs previous 13F -53,190 shares

    6.28% of the 13F portfolio, value $54,727,234.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 2,270,663 shares
    Change vs previous 13F not available

    6.9% of the 13F portfolio, value $62,102,634.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).